Skip to contentL
Lifecore Biomedical, Inc.
L
LFCRLifecore Biomedical, Inc. Q1 2020 · 10-Q
Revenue$138.71M$138.71M+11.3% vs Q1 2019 Net Income-$4.78M-$4.78MN/M vs Q1 2019 EPS Diluted-$0.16-$0.16N/M vs Q1 2019 Gross Profit$15,336,000−6.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lifecore Biomedical, Inc. · CIK 1005286 · Engraved from SEC EDGAR
Operating Cash Flow-$5,439,000N/M Free Cash Flowderived-$15,420,000N/M Margins · derivedGross margin11.1%−2.0 pt vs Q1 2019
Operating margin-3.2%−3.0 pt vs Q1 2019
Net margin-3.4%−3.6 pt vs Q1 2019
ended Aug 25, 2019 · filed Oct 3, 2019 · 39 d after period end